Evidence-Based Prediction of COVID-19 Severity in Hospitalized Children.
Journal
International journal of clinical practice
ISSN: 1742-1241
Titre abrégé: Int J Clin Pract
Pays: India
ID NLM: 9712381
Informations de publication
Date de publication:
2022
2022
Historique:
received:
04
01
2022
accepted:
18
03
2022
entrez:
10
6
2022
pubmed:
11
6
2022
medline:
14
6
2022
Statut:
epublish
Résumé
In this study, by using clinical and paraclinical characteristics, we have aimed to predict the severity of the disease in hospitalized COVID-19 children. This cross-sectional study was conducted on medical records about epidemiologic data, underlying diseases, symptoms, and laboratory tests from March to October, 2020, on 238 hospitalized confirmed COVID-19 paediatric cases in several children's hospitals of Tehran, Ahwaz, Isfahan, and Bandar Abbas. From 238 patients, 140 (59%) were male and most of them were in the age group of 1 to 5 years (34.6%). Among all hospitalized patients, 38% had an underlying disease and in total, 5% of cases were expired. Determining patient severity is essential for appropriate clinical decision making; our results showed that in hospitalized pediatric patients, by using several variables such as SGOT, CRP, ALC, LDH, WBC, O
Identifiants
pubmed: 35685588
doi: 10.1155/2022/1918177
pmc: PMC9159143
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1918177Informations de copyright
Copyright © 2022 Shahnaz Armin et al.
Déclaration de conflit d'intérêts
The authors declare that there are no conflicts of interest.
Références
JAMA Pediatr. 2020 Oct 1;174(10):e202430
pubmed: 32492092
Indian Pediatr. 2020 Jun 15;57(6):533-535
pubmed: 32562397
J Clin Virol. 2020 May;126:104350
pubmed: 32283335
Clin Infect Dis. 2020 Sep 12;71(6):1547-1551
pubmed: 32112072
Pediatrics. 2020 Jun;145(6):
pubmed: 32179660
Arch Acad Emerg Med. 2020 Apr 04;8(1):e43
pubmed: 32259132
Neurosci Lett. 2021 Jan 19;743:135567
pubmed: 33352286
BMJ. 2020 Apr 15;369:m1498
pubmed: 32295759
J Med Virol. 2020 Jun;92(6):564-567
pubmed: 32115733
Eur Respir J. 2020 Apr 23;55(4):
pubmed: 32241833
Clin Chem Lab Med. 2020 Jun 25;58(7):1063-1069
pubmed: 32191623
Allergy. 2020 Jul;75(7):1730-1741
pubmed: 32077115
Cell Host Microbe. 2020 Jun 10;27(6):992-1000.e3
pubmed: 32320677
Indian J Pediatr. 2020 Apr;87(4):281-286
pubmed: 32166607
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
BJOG. 2020 Jun;127(7):786-788
pubmed: 32131142
MMWR Morb Mortal Wkly Rep. 2020 Aug 14;69(32):1081-1088
pubmed: 32790664
North Clin Istanb. 2020 May 04;7(3):284-291
pubmed: 32478302
Open Forum Infect Dis. 2020 Apr 29;7(5):ofaa153
pubmed: 32455147
Science. 2020 May 1;368(6490):473-474
pubmed: 32303591
N Engl J Med. 2020 Jul 9;383(2):187-190
pubmed: 32356945
J Autoimmun. 2020 May;109:102433
pubmed: 32113704
Life Sci. 2020 Aug 1;254:117788
pubmed: 32475810
Emerg Infect Dis. 2020 Oct;26(10):2473-2476
pubmed: 32639228
Obes Res Clin Pract. 2020 Jul - Aug;14(4):375-379
pubmed: 32536475
Rev Med Virol. 2021 Jan;31(1):1-10
pubmed: 32845042
Int J Infect Dis. 2020 Jun;95:304-307
pubmed: 32344011
Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Feb 10;41(2):145-151
pubmed: 32064853
Sci Transl Med. 2020 Oct 7;12(564):
pubmed: 32958614
Lancet. 2020 Mar 28;395(10229):1033-1034
pubmed: 32192578
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143